The Valley Desk

NCT00070499 · Interventional trial

Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia

Overall registry status Active not recruiting

Phase 2

Conditions Chronic Myeloid Leukemia, BCR-ABL1 Positive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov